Blog - Page 3196 of 5756

WednesdayNov 07, 2012 7:35 pm

Integrated Freight Corp. (IFCR) Advances Toward Becoming One of the Largest Freight Carriers in U.S.

Integrated Freight Corp., a publicly traded motor freight company headquartered in Sarasota, Fla., is engaged in long-haul, regional, and local service to its customers. Specializing in dry and refrigerated freight truckload services, the company operates chiefly in well-established traffic lanes in the upper Midwest, the Pacific Northwest, Texas, California, and the Atlantic Seaboard. Incorporated in 2008, Integrated Freight was created for the purpose of acquiring and consolidating mid-sized operating motor freight companies. The company currently operates four subsidiaries – Cross Creek Trucking, Inc.; Morris Transportation, Inc.; Smith Systems Transport, Inc.; and Triple C Transport, Inc. – as independent companies under…

WednesdayNov 07, 2012 10:47 am

VistaGen Therapeutics, Inc. (VSTA) Presents Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced that results of their collaboration with Duke University were presented this week at the American Heart Association 2012 Scientific Sessions in Los Angeles. The presentation, entitled “Human embryonic stem cell-derived cardiac tissue patch with advanced structure and function,” illuminated the important synergistic interactions of VistaGen’s stem cell-derived human cardiomyocytes (heart cells) and Duke’s tissue engineering and analytical technologies. The research, which expands the scope of VistaGen’s drug rescue capabilities focused on heart toxicology, was led at Duke by Dr. Nenad…

WednesdayNov 07, 2012 10:46 am

China Sunergy Co. Ltd. (CSUN) Completes Transactions to Procure Two Solar Park Projects in the UK

China Sunergy Co. Ltd., a specialized solar cell and module manufacturer, announced intentions to invest in two 5MW Solar Parks. The solar parks are located in the southwest of Cornwall region in the UK. China Sunergy will arrange the construction of the projects, and then own and operate these two solar parks itself. The two solar parks will be able to achieve high energy output levels that will increase the economic return due to the high irradiation of above 1,000 kWh per square meters a year. The construction of the two solar parks will begin in the upcoming weeks and…

WednesdayNov 07, 2012 10:44 am

Pointer Telocation Ltd. (PNTR): New Collaboration Will Offer Advanced and Profitable Telematics Applications for Public Transit Systems

Cellocator, a Pointer Telocation Ltd. division and a global leader in fleet management and tracking solutions, and iris-GmbH, a leading provider of sensors for automatic people counting, recently announced plans for collaboration that will offer an integrated fleet management and automatic passenger counting solution for use in the public transit market. This collaboration allows for full integration of the iris IRMA Basic system with Cellocator’s Cello-F device, resulting in accurate passenger counting for effective utilization of vehicles in public transit systems, as well as enabling advanced fleet management and fleet safety applications. Cellocator’s Cello-F platform provides superior functionality and performance…

TuesdayNov 06, 2012 10:59 am

Cardium Therapeutics, Inc. (CXM) Reports European Union’s First Gene Therapy Approval

Today, Cardium Therapeutics announced the EU approval of uniQure’s Glybera® (alipogene tiparvovec). This first gene therapy approval by a major health regulatory authority represents a significant milestone and validation for the gene therapy industry. Glybera® was developed to treat patients diagnosed with an inherited metabolic disease called familial lipoprotein lipase deficiency (LPLD or familial hyperchylomicronemia). The European Commission’s marketing authorization of Glybera covers all 27 European member states. uniQure plans to apply for regulatory approval in the U.S., Canada, and other countries. “The EU approval of Glybera represents a major milestone for the global gene therapy industry,” commented Christopher J.…

TuesdayNov 06, 2012 10:58 am

International Stem Cell Corp. (ISCO) to Host Conference Call to Discuss Q3 2012 Financial Results

Earlier this morning, International Stem Cell Corp. announced that it will be hosting a conference call later this week. Dr. Simon Craw, Executive Vice President of International Stem Cell, and Ms. Linh Nguyen, Chief Financial Officer, will be present to discuss ISCO’s financial results for the three months ended September 30, 2012. Those who wish to attend the call should note the information below: Date: Friday, November 9, 2012 Time: 11:00 a.m. Eastern Time Conference Line (U.S.): 1-877-317-6776 International Dial-In: 1-412-317-6776 Conference ID: 10020806 Webcast: http://webcast.mzvaluemonitor.com/Home/Login/630 Investors are advised to dial in at least 10 minutes before the call. Those…

TuesdayNov 06, 2012 10:54 am

TeleCommunication Systems, Inc. (TSYS) Part of $10 Billion DoD Award

TeleCommunication Systems announced that it has been named one of the twenty awardees under the Global Tactical Advanced Communication Systems and Services (GTACS) contract, which is a multiple-awardee, Indefinite Delivery – Indefinite Quantity (IDIQ) vehicle from the Department of Defense. It has an estimated ceiling of $10 billion over a five year period, which will allow DoD agencies to purchase TeleCommunication’s satellite and support systems. Based in Annapolis, MD, TeleCommunication Systems is focused on the development of mobile communication technology, with components in E9-1-1, text messaging, commercial location, and deployable wireless communications. The company is also involved in cloud computing,…

TuesdayNov 06, 2012 10:53 am

IGI Laboratories, Inc. (IG) to Launch First IGI Labeled Generic Topical Prescription Drug Products

Yesterday, New Jersey-based topical generic pharmaceutical company IGI Laboratories announced it will launch its first IGI labeled generic products later this year. The company has an extensive partnership with Medimetriks Pharmaceuticals, Inc., which is a branded specialty pharmaceutical company focused on the dermatology market. As part of this relationship, IGI serves as Medimetriks’ authorized generic dealer for certain products. On Nov. 1, IGI received authorization to launch generic distribution of certain of Medimetriks’ recently launched Synalar (fluocinolone acetonide) line of prescription topical products. IGI will work closely with Medimetriks to help ensure the successful launch of these generic topical prescription…

TuesdayNov 06, 2012 10:52 am

GlobalWise Investments, Inc. (GWIV) Benefits from Intellinetics Technology

For more than two decades, GlobalWise wholly owned subsidiary Intellinetics has focused on helping organizations operate faster, leaner, and smarter by digging their way out of information. The company’s Enterprise Content Management (ECM) software, deployed via the cloud or stand-alone, is designed to facilitate the storage and access of documents and records, allowing them to flow freely with authorized 24/7 worldwide access. It’s a highly marketable product at a time when up to 85 percent of content, which can be critical to security and compliance issues, is essentially trapped as unstructured data. Intellinetics’ software product architecture is Open Database Compliant…

TuesdayNov 06, 2012 10:51 am

PositiveID Corp. (PSID) Partners with Science Applications International (SAI) to Pursue Defense Threat Reduction Contracts

PositiveID, a developer of airborne bio-threat detection systems for America’s homeland defense industry, has signed a teaming agreement with Science Applications International Corp. (“SAIC”) to pursue indefinite delivery/indefinite quantity contracts with the Defense Threat Reduction Agency (DTRA). The multiple award contracts support the weapons of mass destruction (WMD) – defeat technology, arms control, and nuclear technology electromagnetic research and development/ survivability and infrastructure programs. Per the agreement, which combines SAIC’s system engineering and integration capabilities with PositiveID’s bio-threat detection technologies, PositiveID will offer both its Dragonfly™ Rapid MD-x Cartridge-based diagnostic system as well as its M-BAND airborne bio-threat detector. PositiveID’s…

Site Search

Company Search